Caricamento...

Farnesoid X Receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through down-regulation of HER2 expression

Tamoxifen (Tam) treatment is a first-line endocrine therapy for estrogen receptor α (ERα) positive breast cancer patients. Unfortunately, resistance frequently occurs and is often related with overexpression of the membrane tyrosine kinase receptor HER2. This is the rationale behind combined treatme...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncogene
Autori principali: Giordano, Cinzia, Catalano, Stefania, Panza, Salvatore, Vizza, Donatella, Barone, Ines, Bonofiglio, Daniela, Gelsomino, Luca, Rizza, Pietro, Fuqua, Suzanne A. W., Andò, Sebastiano
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4482257/
https://ncbi.nlm.nih.gov/pubmed/21499302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2011.124
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !